Printer Friendly
The Free Library
14,679,458 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

KeraVision's Assets to Addition Technology.


Business Editors

FREMONT, Calif.--(BUSINESS WIRE)--May 21, 2001

KeraVision, Inc., a vision correction company, today announced that the U.S. Bankruptcy Court bankruptcy court n. the specialized Federal court in which bankruptcy matters under the Federal Bankruptcy Act are conducted. There are several bankruptcy courts in each state, and each one's territory covers several counties. , Oakland Division, has approved a sale of substantially all of KeraVision's assets to Addition Technology, Inc. for $1,033,000.00. The Company expects this sale to close in the next month. After the closing, the Company expects to convert its bankruptcy bankruptcy, in law, settlement of the liabilities of a person or organization wholly or partially unable to meet financial obligations. The purposes are to distribute, through a court-appointed receiver, the bankrupt's assets equitably among creditors and, in most  case to a Chapter 7 liquidation The collection of assets belonging to a debtor to be applied to the discharge of his or her outstanding debts.

A type of proceeding pursuant to federal Bankruptcy
.

In its bankruptcy filing papers, the Company previously cited its inability to obtain sufficient financing and the large capital expenditures required to develop its business as factors that have had an adverse affect on the Company's ability to continue to operate.

The statements contained in this release which are not historical facts may be deemed to contain forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
. Actual results may differ materially from those expressed or implied in any forward-looking statement as a result of certain risks and uncertainties.

Note to Editors: KERAVISION and INTACS Intacs Ophthalmology A device inserted into the periphery of the cornea, reshaping it to correct myopia of –1.0 to –3.0 diopters. See LASIK.  are protected trademarks of KeraVision, Inc. in the U.S. and foreign countries.
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:May 21, 2001
Words:171
Previous Article:MaverickTrader.Com Announces Investment Opinion: Stock Picks Keep Going Up.
Next Article:Phoenix Technologies Announces Immediate Support for the AMD Athlon 4 Processor.
Topics:



Related Articles
Focusing the soul's fuzzy window. (corneal implants to treat presbyopia and myopia) (Brief Article)
KeraVision, Inc. Releases Third Quarter Results; European clinical data announced.
KeraVision Reports Record Revenues for 3rd Quarter; Doctors Trained Reaches 448 as Acceptance of Intacs Grows.
KeraVision Reports First Quarter Results; Procedure Growth Rate Continues to Accelerate.
David Applegate Named VP for Medical Marketing and Business Development; Led Product Launches At Summit and Vistakon.
KeraVision Reports Second Quarter Results.
KeraVision Reports Third Quarter Results; Company Files Registration Statement With SEC, Prepares for Possible Financing Agreement That Could Include...
FDA APPROVES EYE IMPLANTS.(NEWS)
DAILY NEWS STOCK PICKING CONTEST.(Business)(Statistical Data Included)
GROUP EFFORT; INVESTMENT CLUBS AT A LOSS IN COPING WITH DAILY NEWS STOCK CONTEST.(BUSINESS)(Statistical Data Included)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles